Macrocyclic compound and uses thereof
US11725015B2 · kind B2 · utility
1Cited by
38References
8Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Feb 4, 2021 |
| Grant date | Aug 15, 2023 |
| Priority date | — |
| Expiry date | Sep 16, 2041 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/76
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides novel Compound (1) having tumor vascular remodeling effect and/or anti-CAF (Cancer Associated Fibroblasts) activity, or a pharmaceutically acceptable salt thereof, optionally in a pharmaceutically acceptable carrier, and medical uses thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.